Egypt: Curative liver resection (LR) can be safely carried out in carefully selected elderly patients with hepatocellular ...

A novel liver-on-a-chip model can be used to study immune cell interactions in liver cancer and test promising new therapies.

Hepatocellular carcinoma or HCC is the most commonly observed form of liver cancer and the fourth leading cause of ...

A team led by Sylvain Meloche, Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signaling and Cell Growth ...

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...

In this cohort study involving noncirrhotic patients with chronic hepatitis B, a new prognostic model based on viral load was ...

Patients with HCC treated with a combination of the immune checkpoint inhibitor atezolizumab and angiogenesis inhibitor ...

One area where Focus V and penpulimab seem to hold an edge over Elevar’s combination is in their safety profile, with fewer ...

The trial enrolled 1,324 patients with unresectable hepatocellular carcinoma. Credit: Jo Panuwat D / Shutterstock. UK-based pharmaceutical company AstraZeneca has reported positive results from the ...